Syngene Scientific Solutions Limited
About Syngene Scientific Solutions Limited
Data last updated:
Syngene Scientific Solutions Limited is a public limited company based in Bangalore, Karnataka, India, a subsidiary of Syngene International Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 August 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2022PLC164804. Its GSTIN is 36ABJCS1526Q1ZS (Telangana).
The company has an authorised share capital of ₹500 Cr and a paid-up capital of ₹399 Cr. It is led by directors including Kenneth Jay Barr and Deepak Jain.
Its last annual general meeting (AGM) was held on 18 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Newton Room Ground Floor The Hub Tower 8A 360 Degree Business Park, Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹334.5 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹24.4 Cr (net margin 7.3%) and EBITDA of ₹120.2 Cr (EBITDA margin 35.9%).
The company has about 949 employees on its provident fund (EPFO) records.
The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹315 Cr; the latest was in March 2024. Its 4 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 3 smaller; the largest is PPD Pharmaceutical Development India Private Limited with revenue of ₹457.7 Cr. The company has 5 MSME Form 1 returns on record between 2023 and 2024, listing 114 overdue payments to 40 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Syngene Scientific Solutions Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNewton Room Ground Floor The Hub Tower 8A 360 Degree Business Park, Doddathoguru Electronic City Phase 1 Bengaluru, Bangalore, Karnataka, India – 560100
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Syngene Scientific Solutions Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Syngene Scientific Solutions is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
Financials of Syngene Scientific Solutions Limited
FY 2025 filings availableSyngene Scientific Solutions Limited reported revenue of ₹334.5 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA fell 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹120.2 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹24.4 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 35.9% | ||
| Net Profit Margin | 7.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Syngene Scientific Solutions Limited, buy the company report.
Board of directors of Syngene Scientific Solutions Limited
Syngene Scientific Solutions has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kenneth Jay Barr | Director | 24 Mar 2023 | 3 Years 7 Months | Current |
| Deepak Jain | Director | 25 Nov 2024 | 1 Years 11 Months | Current |
| Jayashree Aiyar | Director | 31 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Syngene Scientific Solutions Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| PPD Pharmaceutical Development India Private Limited | ₹457.7 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Syngene Scientific Solutions Limitedthis company | ₹334.5 Cr (FY 2025) | ₹24.4 Cr | 7.3% | -6.0% | Bangalore, Karnataka, India | |
| Curia India Private Limited | ₹282.6 Cr (FY 2025) | 23.0% | Hyderabad, Telangana, India | |||
| Adgyl Lifesciences Private Limited | ₹272.09 Cr (FY 2025) | -8.0% | Bengaluru, Karnataka, India | |||
| Orbicular Pharmaceutical Technologies Private Limited | ₹272.04 Cr (FY 2025) | 41.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Syngene Scientific Solutions Limited, buy the company report.
Auditor
Syngene Scientific Solutions Limited is audited by B S R & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Syngene Scientific Solutions Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Syngene Scientific Solutions Limited, buy the company report.
Deals & funding
Syngene Scientific Solutions Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹315 Cr; the latest was in March 2024.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Funding round | ₹315 Cr | Investors: Syngene International Limited |
| Mar 2023 | Rights issue | ₹83 Cr | Investors: Syngene International Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Syngene Scientific Solutions Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Syngene Scientific Solutions Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 114 overdue payments to 40 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 40)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bureau Veritas India Testing Services Private Limited | |||
| Om Sri Bhavishyath Logistics Private Limited | |||
| Tylt Technologies Private Limited | |||
| Akkayya Hospitality Services | |||
| Angene Chemical Private Limited |
To see the full MSME payment records of Syngene Scientific Solutions Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Syngene Scientific Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABJCS1526Q1ZS | Telangana | Active | 27 Jan 2023 |
To see the full GST registrations and return filing status of Syngene Scientific Solutions Limited, buy the company report.
Recent activity
Syngene Scientific Solutions Limited has 9 board changes on record since 2022: 6 appointments and 3 cessations. The latest: Sibaji Biswas ceased to be Director on 30 Nov 2024.
Frequently asked questions
Syngene Scientific Solutions is an active public limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 August 2022 (4+ years old) and is registered under CIN U73200KA2022PLC164804.
Syngene Scientific Solutions has 3 current directors:
- Kenneth Jay Barr - Director
- Deepak Jain - Director
- Jayashree Aiyar - Director
The latest financial statements of Syngene Scientific Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 July 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Syngene Scientific Solutions is 36ABJCS1526Q1ZS, registered in Telangana.
The CIN (Corporate Identification Number) of Syngene Scientific Solutions is U73200KA2022PLC164804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syngene Scientific Solutions was incorporated on 10 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Syngene Scientific Solutions has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹315 Cr; the latest was in March 2024.
The peers of Syngene Scientific Solutions by revenue are PPD Pharmaceutical Development India Private Limited, Curia India Private Limited, Adgyl Lifesciences Private Limited, Orbicular Pharmaceutical Technologies Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Sibaji Biswas ceased to be Director on 30 Nov 2024. Deepak Jain was appointed as Director on 25 Nov 2024. Jayashree Aiyar was appointed as Director on 31 Jan 2024. Syngene Scientific Solutions has 9 board changes on record in total.
Syngene Scientific Solutions has 5 MSME Form 1 returns on record between 2023 and 2024, listing 114 overdue payments to 40 micro and small suppliers. The latest return was filed on 30 Apr 2024.
The registered office of Syngene Scientific Solutions is at Newton Room Ground Floor The Hub Tower 8A 360 Degree Business Park, Doddathoguru Electronic City Phase 1 Bengaluru, Bangalore, Karnataka, India – 560100.
Syngene Scientific Solutions operates in the pharma industry, in the pharma contract r and d segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
